ReviewClinical reviews in allergy & immunology2010
Diagnostic challenges in celiac disease and the role of the tissue transglutaminase-neo-epitope.
Review in Clinical reviews in allergy & immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Assessment of a Test for the Screening and Diagnosis of Celiac Disease.Journal of clinical laboratory analysis · 2016Article
- Article
- Cutting-edge issues in celiac disease and in gluten intolerance.Clinical reviews in allergy & immunology · 2012Review
- A novel algorithm for the diagnosis of celiac disease and a comprehensive review of celiac disease diagnostics.Clinical reviews in allergy & immunology · 2012Review
- The future of autoimmunity.Clinical reviews in allergy & immunology · 2012Article
- Dermatitis herpetiformis: from the genetics to the development of skin lesions.Clinical & developmental immunology · 2012Review
- Celiac disease and dermatologic manifestations: many skin clue to unfold gluten-sensitive enteropathy.Gastroenterology research and practice · 2012Article
- Newly described clinical and immunopathological feature of dermatitis herpetiformis.Clinical & developmental immunology · 2012Review
- Novel trends in celiac disease.Cellular & molecular immunology · 2011Review
- A new algorithm for the diagnosis of celiac disease.Cellular & molecular immunology · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The diagnosis of celiac disease (CD) remains a clinical challenge based on the incomplete specificity and sensitivity rates of current non-invasive tests. Furthermore, histological assessments fail to identify all overt cases and, in particular, do not manifest pathognomonic alterations in silent cases. Accordingly, the majority of CD cases are diagnosed with great delay. Recent research into the pathogenesis of CD, allowed us to identify a neo-antigen that appears to be the most promising serological tool for the detection of anti-tissue transglutaminase as well as anti-gliadin antibodies.
Indexed as
Identifiers
19629760What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.